SOX13 and myelodysplastic syndrome: Further investigation will be required to understand how the baseline increase in SOX13 expression in MDS iNeurons affects neuronal maturation in vitro. Additionally, we observed that SLC7A5 is down-regulated in MDS iNeurons and increased after ASO treatment in both MDS and unaffected control iNeurons.